GW Integrative Medicine14 Feb 2023

Psilocybin & Alzheimer’s Disease

Today, we talk about psilocybin and Alzheimer’s with Albert Garcia-Romeu, PhD, a member of the Psychiatry and Behavioral Sciences faculty at the Johns Hopkins University School of Medicine. Dr. Albert Garcia-Romeu is a also a Guest Researcher at the National Institute on Drug Abuse Intramural Neuroimaging Research Branch. His research examines the effects of psychedelics in humans, with a focus on psilocybin as an aid in the treatment of addiction. Dr. Garcia’s current research interests include clinical applications of psychedelics, mindfulness, and altered states of consciousness and their underlying neurobiological mechanisms, and the role of spirituality in mental health and addiction. ◘ Related Links Johns Hopkins University Center for Psychedelic and Consciousness Research bit.ly/3DQHcwM Psilocybin & Alzheimer's Clinical Trial Participant Screening Form bit.ly/3XbvWSN Video: Psilocybin for Depression in early Alzheimer's Disease Clinical Trial at John Hopkins bit.ly/40DFitf Dr. Albert Garcia-Romeu bio bit.ly/3I2GWw0 ◘ Transcript bit.ly/3RZqgu3 ◘ This podcast features the song “Follow Your Dreams” (freemusicarchive.org/music/Scott_Ho…ur_Dreams_1918) by Scott Holmes, available under a Creative Commons Attribution-Noncommercial (01https://creativecommons.org/licenses/by-nc/4.0/) license. ◘ Disclaimer: The content and information shared in GW Integrative Medicine is for educational purposes only and should not be taken as medical advice. The views and opinions expressed in GW Integrative Medicine represent the opinions of the host(s) and their guest(s). For medical advice, diagnosis, and/or treatment, please consult a medical professional.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(119)

Welcome to the Elder Evolution: Psychedelics & Older Adults

The Baby Boom generation pioneered the counterculture movement of the 1960s so it's not so surprising that 50 years later they are using compounds like psilocybin and LSD with the goal to improve thei...

27 Mai 31min

Feds Reclassify Medical Cannabis: What You Need to Know

Boy howdy do we have something to talk about with our favorite medical cannabis subject matter expert today! On April 23, 2026, the U.S. Department of Justice (DOJ) and the Drug Enforcement Administ...

2 Mai 1h 44min

How Loneliness Affects Your Health

When we think about loneliness, we don’t associate it with risks comparable to smoking up to 15 cigarettes a day. But a growing body of research shows that loneliness significantly impairs physical an...

2 Mar 25min

The Tip of the Trauma Iceberg: Adverse Childhood Experiences

The U.S. Centers for Disease Control & Prevention reports that preventing adverse childhood experiences (ACEs) like abuse, neglect, household dysfunction could reduce the number of adults with depress...

17 Feb 46min

The Gut-Brain-Dementia Connection

A new study by a GW-led research team suggests gut bacteria may be linked to memory decline in mild cognitive impairment, or MCI, and some dementia diseases. Published in Alzheimer's & Dementia: The ...

30 Jan 36min

The New Dietary Guidelines for Americans: It's a Mixed Bag

The USDA and HHS just released new Dietary Guidelines for Americans. We dig into the new guidelines with Dr. Leigh Frame, our favorite nutrition scientist, co-host of the pod, and co-director of the F...

9 Jan 35min

What the Hemp?

We talk with Peter Grinspoon, MD—an internationally renowned expert on medical cannabis, drug policy, and addiction—about the U.S. Congress recriminalizing most hemp-derived products. The measure is...

10 Des 202539min

The Longevity Nutrient

Dr. Stephanie Venn-Watson, who co-discovered the C15 essential fatty acid, returns to the podcast to discuss her new book “The Longevity Nutrient: The Unexpected Fat That Holds the Key to Healthy Agin...

28 Nov 202532min